Balbronn, France

Jean-Noel Collard



Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Bischheim, FR (1989)
  • Balbronn, FR (1995 - 1996)
  • Illkirch, FR (1996)
  • Illkirch Graffenstaden, FR (1997)

Company Filing History:


Years Active: 1989-1997

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Jean-Noel Collard

Introduction

Jean-Noel Collard is a notable inventor based in Balbronn, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurological disorders. With a total of 8 patents to his name, Collard's work has had a meaningful impact on medical science.

Latest Patents

Among his latest inventions are acetylcholinesterase inhibitors. This invention relates to silylated aromatic fluoroketones possessing acetylcholinesterase-inhibiting properties and their use in the treatment of Alzheimer’s disease and senile dementia. Additionally, he has developed aromatic acetylcholinesterase inhibitors, which further enhance the therapeutic options available for these conditions.

Career Highlights

Collard has worked with prominent companies in the pharmaceutical industry, including Merrell Pharmaceuticals, Inc. and Merrell Dow Pharmaceuticals. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Throughout his career, Collard has collaborated with esteemed colleagues such as Daniel G. Schirlin and Jean-Marie Hornsperger. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in pharmaceutical research.

Conclusion

Jean-Noel Collard's contributions to the field of pharmaceuticals, particularly in the development of treatments for Alzheimer’s disease, highlight his importance as an inventor. His work continues to inspire advancements in medical science and improve the lives of those affected by neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…